Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE‐LY Trial

Abstract

Background

Hijazi Z; Verdecchia P; Oldgren J; Andersson U; Reboldi G; Di Pasquale G; Mazzotta G; Angeli F; Eikelboom JW; Ezekowitz MD

Journal of the American Heart Association, Vol. 8, No. 2,

Ovid Technologies (Wolters Kluwer Health)

January 22, 2019

10.1161/jaha.118.010107

John Eikelboom

Salim Yusuf